PolyFun drug
Evidence from:
primary |
all sources
Related entities (11)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| GCTA-COJO | interacts_with | PolyFun | — | 1 |
| PolyFun | interacts_with | causal SNP | — | 1 |
| PolyFun | interacts_with | FINEMAP | — | 1 |
| PolyFun | associated_with | height | — | 1 |
| PolyFun | associated_with | number of children | — | 1 |
| PolyFun | regulates | SNP | — | 1 |
| PolyFun | interacts_with | SNP | — | 1 |
| PolyFun | targets | SNP | — | 1 |
| PolyFun | interacts_with | SuSiE | — | 1 |
| PolyFun | interacts_with | UK Biobank | — | 1 |
| PolyFun | associated_with | UK Biobank | — | 2 |
Mentioned in (3)
Papers in which this entity is mentioned.
- MUSSEL: Enhanced Bayesian polygenic risk prediction leveraging information across multiple ancestry groups. (2024)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Functionally informed fine-mapping and polygenic localization of complex trait heritability. (2020)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| polyfun | drug | 3 | 14 |
| polyfun30 | drug | — | — |